Please provide your email address to receive an email when new articles are posted on . The JADA system decreased abnormal postpartum uterine bleeding in vaginal and cesarean birth, regardless of ...
The Jada System is comprised of an intrauterine device that utilizes low level vacuum to induce normal contraction of the uterus. The Food and Drug Administration has cleared updates to the Jada ® ...
Please provide your email address to receive an email when new articles are posted on . Treatment success for the JADA system was high for both vaginal and cesarean births. Overall, 2.8% of women in ...
The Organon board of directors has approved the deal. The transaction is expected to close in the first quarter of 2026, subject to required regulatory approvals. “I am incredibly proud of the work ...
The women’s health company Organon has put forward the first real-world data collected from its Jada system, a device used to help stop excessive and potentially life-threatening bleeding following ...
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for ...
Organon, a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of ...
Postpartum hemorrhage - severe bleeding after childbirth - is a leading cause of maternal deaths worldwide. There have been few innovations in treatment in recent years. In a new study to be presented ...
Media Contacts: Karen Addis, APR, karen@addispr.com; 301-787-2394; Kerri Wade, MPA, kwade@smfm.org, 202-236-1780 San Francisco, Calif. -- Postpartum hemorrhage — severe bleeding after childbirth — is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results